Katja E Odening
24PUBLICATIONS
92CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (24)
Sort by Publication Date:
|Mar 14, 2026
Sex- and age-dependent differences in detrimental repolarization-prolonging effects of doxorubicin: Evidence of cardiac toxicity beyond heart failure.Miriam Barbieri, Katja E Odening
|Jan 19, 2026
Mechano-electrical feedback in transgenic rabbit models of long QT syndrome Type 2 and short QT syndrome Type 1.Nicolò Alerni, Melania Buonocunto, Saranda Nimani
|Oct 15, 2025
Towards a personalized, mechanism-based risk prediction of post-operative atrial fibrillation.Lucilla Giammarino, Katja E Odening
|Aug 30, 2025
AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome.Saranda Nimani, Sahej Bains, Nicolò Alerni
|Aug 12, 2025
Beneficial action potential duration-shortening effects, but deleterious negative inotropism of IKs-activator docosahexaenoyl glycine in long QT syndrome type 2.Julien Louradour, Tibor Hornyik, Alicia De la Cruz
|Jul 21, 2025
Current and future precision therapy approaches in the long QT syndrome.Saranda Nimani, Miriam Barbieri, Marina Rieder
Pageof 4
Frequent Collaborators
7 joint publications
Lucilla Giammarino
5 joint publications
Saranda Nimani
5 joint publications
Miriam Barbieri
5 joint publications
Michael Brunner
4 joint publications
Julien Louradour
4 joint publications
Jordi Heijman
4 joint publications
Ruben Lopez
3 joint publications
Nicolò Alerni
3 joint publications
Michael J Ackerman
2 joint publications
Lluis Matas
